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Angiogenesis, which is essential for tumour growth and metas-
tasis, depends on the production of angiogenic factors by tumour
cells and normal cells (Folkman, 1986). Increased vascularity
enhances the growth of primary neoplasms and provides an
avenue for haematogenous metastasis (Folkman, 1990). Indeed,
recent studies have shown that the incidence of metastasis can be
correlated with the number and density of blood vessels in breast
(Weidner et al, 1991), lung (Macchiarini et al, 1992), prostate
(Weidner et al, 1993), cervical (Smith-MacCune et al, 1994),
oesophageal (Kitadai et al, 1998a), colon (Takahashi et al, 1995)
and gastric carcinomas (Takahashi et al, 1996; Tanigawa et al,
1996) and melanoma (Graham et al, 1994).
There have been many studies attempting to isolate the molec-
ular mediators of this process. Among the possibilities is inter-
leukin-8 (IL-8), a member of the CXC chemokine family. This
cytokine was initially shown to selectively stimulate chemotactic
activity for neutrophils and lymphocytes (Matsushima et al, 1988,
1992). More recent studies revealed that IL-8 is multifunctional: it
can induce angiogenesis (Koch et al, 1992; Strieter et al, 1992),
haptotactic migration (Wang et al, 1990) and proliferation of
keratinocytes and melanoma cells (Krueger et al, 1990;
Schandendorf et al, 1993). Human recombinant IL-8 can induce
proliferation and migration of human umbilical vein endothelial
cells (HUVECs) and is potently angiogenic when implanted in the
rat cornea (Strieter et al, 1992). Furthermore, IL-8 is a known
angiogenic factor for human lung carcinoma (Strieter et al, 1995),
human bladder carcinoma (Tachibana et al, 1997) and human
prostate carcinoma (Green et al, 1997). The CXC chemokines
IL-8 and interferon-a-inducible protein (IP-10) have recently been
shown to regulate angiogenic activity in idiopathic pulmonary
fibrosis (Keane et al, 1997).
The expression of a wide variety of growth factors/receptors
and cytokines, including epidermal growth factor (EGF) trans-
forming growth factor (TGF-a), EGF receptor (EGF-R) (Tahara,
1990, 1993), IL-1 (Ito et al, 1993) and IL-6 (Ito et al, 1997) by
human gastric carcinoma cells has been shown to correlate with
malignant potential. Gastric carcinoma cells also produce angio-
genic factors, including basic fibroblast growth factor (bFGF)
(Tanimoto et al, 1991) and vascular endothelial growth factor
(VEGF) (Yamamoto et al, 1998). We have recently found that
surgical specimens of human gastric carcinomas overexpress IL-8
as compared to corresponding normal mucosa, and that the IL-8
mRNA level directly correlated with the vascularity of the
tumours (Kitadai et al, 1998b).
There have not, however, been any studies that established a
causal role for IL-8 in gastric cancer angiogenesis. The purpose of
this study was, therefore, to provide evidence for the causal role of
IL-8 in the growth and vascularization of human gastric cancer.
We show that stably IL-8-transfected human gastric cancer cells
produce angiogenic activity in culture. Subsequent to orthotopic
implantation into nude mice, the cells produce rapidly growing
and highly vascularized tumours.
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carcinoma cells (low endogenous IL-8) with an IL-8 expression vector or control vector. Transfection with IL-8 did not affect the proliferation of
cultured cells, yet the culture supernatants of the transfected (but not control) cells stimulated proliferation of human umbilical vein endothelial
cells. The IL-8-transfected and control cells were injected into the gastric wall of nude mice. IL-8-transfected cells produced rapidly growing,
highly vascular neoplasms as compared to control cells. These results provide direct evidence for the role of IL-8 in the angiogenesis and
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Cell cultures and tumour tissues
A human gastric carcinoma cell line, TMK-1 was established in
our laboratory from a poorly differentiated adenocarcinoma
(Ochiai et al, 1985). HUVECs (umbilical cord, human endothelial
cells) were obtained from Dainippon Pharmaceutical Co. Ltd
(Osaka, Japan). TMK-1 cells were routinely maintained in RPMI-
1640 (Nissui Co. Ltd, Tokyo, Japan) with 10% fetal bovine
serum (FBS) (M A Bioproducts, Inc., Walkersville, MD, USA).
HUVECs were maintained in gelatin-coated dishes (Falcon
Laboratories, McLean, VA, USA) in MCDB 131 medium (Life
Technologies, Rockville, MD, USA) containing 10% FBS and
10 ng ml–1 bFGF (Dainippon).
Expression vectors
A full-length IL-8 cDNA (EcoRI-EcoRI, 1.5 kb) (Matsushima
et al, 1988) was inserted into the EcoRI site of pUC 19. A SmaI-
BamHI fragment was cloned into the SmaI-BamHI sites of
Bluescript KS(+) (Stratagene, La Jolla, CA, USA). The resultant
Bluescript KS(+) was digested with XhoI-NotI and cloned into the
XhoI-NotI site of the BCMGS-Neo expression vector (kindly
provided by Dr H Karasuyama, Tokyo Metropolitan Research
Institute of Clinical Medicine, Tokyo, Japan). Expression of IL-8
cDNA was under the control of the cytomegalovirus promoter.
Transfection assays and production of stable cell lines
Transfections were performed by the lipofection method (Life
Technologies) with the following modifications: approximately
106 TMK-1 cells were plated into culture dishes (90-mm diameter)
1 day prior to transfection. On the following day, the growth
medium was replaced, and 3 h later, liposomes containing 5 mg of
the expression plasmid were applied to the cells and left for 6 h.
After that, cell monolayers were rinsed with RPMI containing
400 mg of G418 ml–1 (selection medium). The selection medium
was changed every 3 days.
RNA preparation and Northern blot analysis
Polyadenylated mRNA was extracted from gastric carcinoma cells
using the FastTrackTM mRNA isolation kit (Invitrogen Co., San
Diego, CA, USA). mRNA was electrophoresed on 1% denaturing
formaldehyde/agarose gel, electrotransferred at 0.6 A to a
GeneScreen nylon membrane (DuPont Co., Boston, MA, USA),
and UV cross-linked with 120 000 mJ cm–2 using a UV
Stratalinker 1800 (Stratagene). Hybridizations were performed as
described previously (Radinsky, 1987). Nylon filters were washed
at 65°C with 30 mM sodium chloride, 3 mM sodium citrate
(pH 7.2), and 0.1% sodium dodecyl sulphate (w/v).
DNA probes
The cDNA probes used in these analyses were a 1.3-kb PstI cDNA
fragment corresponding to rat glyceraldehyde 3-phosphate de-
hydrogenase (GAPDH) (Clontech, Palo Alto, CA, USA) and a 0.5-
kb  EcoRI cDNA frgament corresponding to human IL-8
(Matsushima et al, 1988). A 0.7 kb human VEGF cDNA probe and
a 0.8-kb bFGF cDNA probe were kindly provided by Dr M Shibuya
(University of Tokyo, Tokyo, Japan) and Dr J A Abraham
(California Biotechnology, Inc., CA, USA), respectively. Each
cDNA fragment was purified by agarose gel electrophoresis, recov-
ered using GeneClean (BIO 101, Inc., La Jolla, CA, USA), and radi-
olabelled using the random primer technique with 32P-labelled
deoxyribonucleotide triphosphates (Feinberg and Vogelstein, 1983).
Enzyme-linked immunosorbent assay for IL-8 protein
IL-8 levels in cell-free culture supernatants from transfected TMK-1
cells and homogenates of xenografts were assayed by enzyme-
linked immunosorbent assay (ELISA) as described previously (Kita
et al, 1992; Kitadai et al, 1998b) using an IL-8 monoclonal antibody.
The detection limit of the assay was 20 mg ml–1, and inter- and intra-
assay variations were 4.1–4.5% and 7.9–9.3%, respectively.
Immunohistochemical staining
Consecutive 4-mm sections were cut from each study block.
Sections were immunostained for IL-8 and CD31 (specific for
mouse endothelial cells). Immunohistochemistry (IHC) was
performed by the immunoperoxidase technique with minor modi-
fication (Gutman et al, 1995; Kitadai et al, 1998b). Antibodies
used were a rabbit polyclonal antibody (Otsuka Pharmaceutical
Co. Ltd, Tokushima, Japan) at a 1:100 dilution for IL-8, and a
rat monoclonal antibody (Pharmingen, San Diego, CA, USA) for
CD31. Negative controls were done using non-specific IgG as the
primary antibody.
Vessel density
Vessel count was assessed by light microscopy in IHC-stained
areas of the tumour containing the highest numbers of capillaries
and small venules at the invasive edge (Weidner et al, 1991).
Highly vascular areas were first identified by scanning tumour
sections at low power (´40 and ´100). Vessel count was deter-
mined in six such areas at ´400 field (´40 objective and ´10
ocular), and the average count of the six fields was determined.
Vessel lumen was not necessary for a structure to be defined as a
vessel (Weidner et al, 1991).
Cell growth in vitro
Cells (5 ´ 103) were seeded on 24-well plates (Falcon
Laboratories, McLean, VA, USA) and cultured in RPMI medium
in the absence or presence of FBS. The medium was changed
every 48 h. Cell number was determined in triplicate cultures.
MTT assay
HUVECs (5 ´ 103) were plated into multiple 38-mm2 wells of 96-
well gelatin-coated plates (Falcon Laboratories, McLean, VA,
USA) in cultured medium from the transfected TMK-1 cells. The
cells were cultured for 2 days, when their proliferation was deter-
mined by an MTT assay (Fan et al, 1990). Fifty microlitres of
MTT (40 mg ml–1) was added to each well, incubated for 1 h, aspi-
rated and dissolved in dimethyl sulphoxide. The intensity of colour
adduct formation was measured using an ELISA plate reader. The
percentage increase in cell growth was calculated as: growth stim-
ulation (%) = (B–A)/A ´ 100 where A is the A540 of the control
cultures and B is the A540 of test cultures. IL-8 neutralization
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Pharmaceutical Co. Ltd).
Growth of transfected tumour cells in nude mice
Male athymic BALB/c nude mice were obtained from Charlsriver
Co. Ltd (Tokyo, Japan). The mice were maintained under specific
pathogen-free conditions and used when 8 weeks old. To produce
tumours, cultured cells were harvested by a brief trypsinization,
and 5 ´ 105 or 1 ´ 106 viable cells were implanted into the gastric
wall of nude mice as described previously (Takahashi et al, 1995).
Six weeks later, the mice were killed and the tumours growing in
the stomach were removed, weighed and examined histologically.
Statistical analysis
The significance of the in vitro data was analysed by the Student’s
t-test (two-tailed), and the in vivo data was analysed by the
Mann–Whitney  U-test.
RESULTS
Transfection of TMK-1 cells with the IL-8 expression
vector
We used the TMK-1 cell line derived from poorly differentiated
adenocarcinoma because its expression level of IL-8 is extremely
low (Kitadai et al, 1998b). First, we transfected the IL-8 expres-
sion vector (IL-8-BCMGS-neo) into the TMK-1 gastric carcinoma
cells and selected stable IL-8-overexpressing clones. ELISA
demonstrated that clone 15 secreted the highest level of IL-8
protein into the culture medium (Table 1); this clone was used in
subsequent experiments. The IL-8 mRNA expression and cytosol
localization of IL-8 protein were confirmed by Northern blot and
IHC analyses respectively (Figure 1). As a control, we used the
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Table 1 Secretion of IL-8 protein by TMK-1 cells transfected with the IL-8
gene
Secretion of IL-8 protein
Cell line (pg ml–1 10–4)
TMK-1 parental 40.5 ± 1.3
TMK-1 neo 37.4 ± 2.3
TMK-1 IL-8-C1 42.5 ± 3.2
TMK-1 IL-8-C3 43.2 ± 2.8
TMK-1 IL-8-C9 754.0 ± 8.5
TMK-1 IL-8-C15 3512.0 ± 31.0
Cells were incubated in medium supplemented with 10% FBS. Culture
supernatants were collected after 48 h and assayed for IL-8 by ELISA as
described in the Material and Methods section. The values are the mean ±
s.d. of triplicate cultures. This is one representative experiment of three.
IL-8
GAPDH -1.3 kb
-1.8 kb
TMK-1 neo
TMK-1 IL-8 C15
parental
neo
IL-8 C15
AB
Figure 1 Expression of IL-8 mRNA (A) and protein (B) by TMK-1 cells
transfected with IL-8 gene. (A) Five micrograms of polyadenylated selected
RNA were subjected to Northern blot analysis by using 32P-labelled IL-8
cDNA as described in Materials and Methods. A GAPDH probe was used as
an internal control. (B) Immunohistochemistry for IL-8 of transfected TMK-1
cells. Note that IL-8 immunoreactivity is detected within the cytoplasm of
TMK-1-IL-8-C15 cells but not within the TMK-1 neo cells
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Figure 2 In vitro growth of the TMK-1 cells transfected with IL-8 gene. Cells (5 ´ 103 per well) were seeded onto 24-well plates and cultured in RPMI medium
in the presence (A) or absence (B) of 10% FBS. Cell number was counted in triplicate cultures. This is one representative experiment of threeBCMGS-neo plasmid containing the neo-resistance gene but not
IL-8 cDNA under control of the same promoter. The IL-8 produc-
tion by control vector transfectant (TMK-1 neo) was similar to that
of parent cells (Table 1 and Figure 1). We next examined whether
the IL-8 protein produced by the IL-8 transfectant was biologically
active. Since IL-8 has been reported to stimulate proliferation and
migration of HUVECs (Koch et al, 1992; Kitadai et al, 1998b), we
determined whether culture supernatants induced proliferation of
HUVECs. Proliferation of HUVECs was significantly stimulated
by the addition of medium conditioned by the IL-8 transfectants
as compared to that from control cells. The growth stimulatory
activity was blocked by neutralizing antibodies to IL-8 (Table 2).
Effect of IL-8 transfection on in vitro growth of gastric
carcinoma cells
Since IL-8 has been reported to be an autocrine growth factor for
melanoma cells (Schandendorf et al, 1993), we next analysed
whether IL-8 transfection stimulates the in vitro growth of gastric
carcinoma cells. Under both serum-free and serum-containing
conditions, cell growth was not affected by transfection with the
IL-8 gene (Figure 2). This finding agreed with our previous data
showing that the addition of exogenous IL-8 did not alter cell
proliferation of gastric carcinoma cell lines (Kitadai et al, 1998b).
In vivo growth of IL-8-transfected gastric carcinoma
cells
Next, we injected the control and IL-8-transfected cells into nude
mice. Since the organ microenvironment influences tumour
growth and metastasis, the cells were injected into an orthotopic
site (gastric mucosa) of nude mice (Fidler, 1990). As shown in
Table 3, transfection of TMK-1 with IL-8 increased their tumori-
genicity; namely, by 6 weeks after injection of 5 ´ 105 cells, IL-8-
transfected cells formed tumours in seven of ten nude mice,
whereas control cells (TMK-1 neo) did not form any. In addition,
the size of gastric tumours produced by the 1 ´ 106 IL-8-trans-
fected cells was significantly larger than that produced by control
cells (Table 3). Stable expression of IL-8 mRNA and protein in the
tumour lesions were confirmed by Northern blot analysis and
ELISA respectively (Figure 3). Transfection with IL-8 gene did
not change the expression levels of mRNA for VEGF and bFGF
(Figure 3A). Immunohistochemical analysis confirmed the expres-
sion of IL-8 at the cell level. IL-8 immunoreactivity within the
tumours localized mainly to cancer cells (Figure 4A). Normal
epithelial cells and stromal cells showed minimal IL-8 staining
with IHC (data not shown). Distant haematogeneous or peritoneal
dissemination was not found in any of the injected mice.
Effect of IL-8 transfection on angiogenesis of
orthotopic xenografts
To determine whether the increased tumorigencity and growth of
the tumours was associated with increased angiogenesis, we
performed IHC against CD31 (mouse endothelial cell-specific)
and counted microvessels in the orthotopic tumours. A representa-
tive IHC for CD31 is shown in Figure 4. The IL-8 transfection
resulted in stimulation of angiogenic responses. Namely, tumour
vessel density in the tumours produced by the IL-8 transfectants
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Table 3 Effect of IL-8 transfection on tumorigenicity of TMK-1 human gastric
carcinoma cells
Inoculum dose Cell line Tumorigenicitya Tumour weight (mg)b
5 ´ 105 TMK-1 neo 0/10 Not determined
TMK-1 IL-8-C15 7/10c Not determined
1 ´ 106 TMK-1 neo 3/10 12.3 ± 3.1
TMK-1 IL-8-C15 8/10c 125.6 ± 33.4c
aNumber of positive mice/number of injected mice. bMean ± s.e.m. 6 weeks
after orthotopic implantation. cP < 0.01.
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Table 2 Growth stimulation of HUVEC by medium conditioned by IL-8-
transfected TMK-1 cells
Growth stimulation of HUVEC cellsa
Cell line (% of control)
TMK-1 parental (control) 100 ± 9.1
TMK-1 neo 105 ± 11.4
TMK-1 IL-8-C15 185 ± 20.4b
TMK-1 IL-8-C15 + IL-8 Ab 109 ± 15.6
aHUVEC cells (5 ´ 103 cells/well) were incubated with culture supernatants
(200 ml) of TMK-1 lines. After 48 h, growth stimulation was determined by the
MTT assay as described in Material and Methods. The percentage of growth
stimulation was calculated by comparison with HUVEC cells cultured in
medium conditioned by TMK-1 parent cells. Values are mean ± s.d. of
triplicate cultures. bP < 0.01
B
Figure 3 Expression of IL-8 mRNA (A) and protein (B) in the TMK-1
tumours growing in the stomach wall of nude mice. (A) Five mg of
polyadenylated selected RNA were subjected to Northern blot analysis by
using 32P-labelled IL-8, VEGF, bFGF, GAPDH cDNA as described in
Materials and Methods. A GAPDH probe was used as an internal control.
(B) Tumour tissues were homogenized in PBS. Supernatants, obtained by
centrifugation (1800 rpm for 10 min), were assayed for the presence of IL-8
by ELISA. The values are the mean ± s.e.m. of triplicate sampleswas significantly higher than that in control tumours (65.3 ± 5.3
(n = 8) vs 21.7 ± 3.4 (n = 3) vessels per HPF, P < 0.01).
DISCUSSION
IL-8 is a multifunctional cytokine originally identified as a leuco-
cyte chemoattractant (Matsushima et al, 1988, 1992). It can induce
migration in some tumour cells (Wang et al, 1990) and has been
implicated in the induction of angiogenesis in such diverse diseases
as psoriasis (Schroeder and Christopher, 1986), rheumatoid arthritis
(de Marco et al, 1991), idiopathic pulmonary fibrosis (Keane et al,
1997) and some malignant diseases (Folkman, 1986, 1990).
Previous studies have demonstrated that IL-8 is expressed by lung
(Strieter et al, 1995), bladder (Tachibana et al, 1997), prostate
(Green et al, 1997) and head and neck squamous carcinomas
(Richards et al, 1997), astrocytoma (Van Meir et al, 1992) and
malignant melanoma (Schandendorf et al, 1993; Singh et al, 1994).
It has been reported that IL-8 acts as an angiogenic factor in lung
carcinoma (Smith et al, 1994; Strieter et al, 1995; Arenberg
et al, 1996); however, the function of IL-8 in the other carcinomas
has not been clarified. Recently, we found that most gastric carci-
nomas express IL-8 mRNA and protein, and its level directly corre-
lates with angiogenic activity in the tumour (Kitadai et al, 1998b).
In the present study, we performed transfection experiments to
obtain direct evidence that IL-8 regulates angiogenesis in gastric
carcinoma. IL-8 expression vector was stably transfected into TMK-
1 cells (which express negligible levels of IL-8 mRNA and protein)
(Kitadai et al, 1998b). Transfection with the IL-8 gene did not affect
in vitro cell proliferation; however, enforced expression of IL-8 in
TMK-1 cells increased their tumorigenic and angiogenic potential in
the gastric wall of nude mouse (orthotopic site), thus providing
direct evidence for the involvement of IL-8 in angiogenesis.
Although IL-8 transfection increased tumorigenicity and angio-
genicity, neither control nor IL-8 transfectants produced distant
metastasis. To produce metastasis, tumour cells must complete a
series of sequential and selective steps that include growth, vascu-
larization, invasion, adhesion and extravasation (Fidler, 1990).
The increase in angiogenic activity by IL-8 transfection may be
necessary but not sufficient to produce metastasis by TMK-1 cells.
Angiogenic factors produced by tumour cells and normal cells
are critical to the formation of a vascular bed necessary to support
tumour growth at the primary and metastatic sites. Because of the
complex nature of the angiogenic process, it is unlikely that any
one factor is responsible for angiogenesis in a particular tumour
type. Within any individual tumour, there may be a dominant
angiogenic factor that favours the imbalance of the positive and
negative regulators to induce angiogenesis. The two most potent
angiogenic molecules are VEGF and bFGF. We previously studied
the expression of VEGF and bFGF as well as IL-8 in human
gastric carcinoma. The expression level of bFGF is very low and is
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Figure 4 Immunohistochemistry for IL-8 (A, C) and CD31 (B, D) of TMK-1 orthotopic xenografts. Note that IL-8 immunoreactivity is detected within TMK-1
IL-8-C15 cells (C) but not TMK-1 neo cells (A). The vascularity is higher in TMK-1-IL-8-C15 tumours (D) as compared with TMK-1 neo tumours (B); ´250associated with fibrosis in the diffuse type gastric carcinoma
(Tanimoto et al, 1991). On the other hand, VEGF is commonly
expressed by all the gastric carcinoma cell lines and carcinoma
tissues as well as normal mucosa (Yamamoto et al, 1998). Among
these angiogenic molecules, IL-8 correlates best with vascularity
in the tumours. In addition, we demonstrated that overexpression
of IL-8 induced an angiogenic response. Therefore, IL-8 actually
regulates angiogenesis in human gastric carcinomas. In this study,
we examined the expression of VEGF and bFGF by IL-8 transfec-
tants. There were no changes in the levels of mRNA for VEGF and
bFGF after transfection with the IL-8 gene (Figure 3A), indicating
that these factors did not play a role in the increased angiogenic
activity in this system. Smith et al demonstrated that inhibition of
IL-8 using neutralizing antibody resulted in the marked attenua-
tion of angiogenesis in bronchogenic carcinoma (Smith et al,
1994). To prove a possibility for therapeutic intervention for
gastric carcinoma, additional studies with neutralizing IL-8 anti-
body should be required.
IL-8 has been reported to act as an autocrine growth factor for
melanoma cells (Schandendorf et al, 1993) and the expression level
of IL-8 by human melanoma cells correlates with their metastatic
potential (Singh et al, 1994). Furthermore, IL-8 up-regulates colla-
genase type IV mRNA expression and collagenase activity by
melanoma cells (Luca et al, 1997) and stimulate cell motility
(Wang et al, 1990). Recent studies have shown that IL-8 receptors,
IL-8RA and IL-8RB, are expressed by not only microvessel
endothelial cells but also tumour cells in head and neck squamous
cell carcinoma (Richards et al, 1997) and breast carcinoma (Miller
et al, 1998). Therefore, IL-8 may play an important role in tumour
growth and progression by both autocrine and paracrine mecha-
nisms. It would be of great interest to elucidate whether IL-8 recep-
tors are expressed by gastric carcinoma cells.
In conclusion, this study demonstrates that IL-8 produced by
gastric carcinoma cells regulates angiogenesis. The identification
of factors that correlate with angiogenesis in gastric carcinoma
may provide a basis for the design of therapeutic approaches.
Studies to determine if attenuation of IL-8 production by gastric
carcinomas can produce therapeutic benefits are under way.
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